Bio International Pharma Ltd.
Bio International Pharma Ltd. is a professionally managed pharmaceutical distribution company headquartered in the Republic of Yemen. Established in 2015, the company was founded with the objective of building a structured, compliance-driven pharmaceutical supply operation capable of serving both international manufacturers and healthcare institutions across Yemen.
From inception, growth has been capability-driven rather than volume-driven. Investment has prioritized operational infrastructure, regulatory alignment, cold chain capacity, and disciplined governance systems — creating a distribution organization built for long-term sustainability.
Today, Bio International Pharma Ltd. operates a nationwide network serving institutional and professional healthcare customers through structured logistics, regulatory compliance, and integrated market access support.
Bio International Pharma Ltd. operates as a registered limited liability company under the commercial laws of the Republic of Yemen.
The company holds active pharmaceutical import and wholesale distribution licenses issued by the Supreme Medical and Pharmaceutical Authority (SBDMA), authorizing the importation, storage, and distribution of pharmaceutical products within the national territory.
Operational procedures align with WHO Good Distribution Practice (GDP) guidelines, reinforcing standardized quality management, documented handling protocols, and regulatory compliance across all supply chain activities.
To deliver high-quality pharmaceutical products from international manufacturing partners to healthcare institutions across Yemen through GDP-aligned distribution operations, specialized cold chain logistics, and proactive market access services—ensuring availability, integrity, and affordability at every stage of the supply chain.
To ensure that essential pharmaceutical products reach the healthcare providers and patients who need them, by operating a distribution network built on quality, compliance, and unwavering supply continuity.
To become Yemen’s most trusted leading GDP-compliant pharmaceutical distributor, trusted by international manufacturers as the preferred local partner for specialty and biological products, and recognized by healthcare providers for reliable, compliance, and continuity of supply.
The principles that guide every decision
Six principles define how Bio International Pharma Ltd. operates, partners, and grows:
Every product and process is held to the highest standard, from source verification to final delivery. Quality is not a department—it is an operational discipline applied across the entire supply chain.
Healthcare systems depend on uninterrupted access to medicine. We maintain the infrastructure, inventory discipline, and logistics capacity to deliver consistently—even in challenging operating environments.
All activities are governed by applicable regulatory frameworks, transparent business practices, and a zero-tolerance approach to non-compliance. We adhere to SBDMA regulations and international good distribution standards.
We invest in long-term relationships with manufacturers and healthcare customers alike, building trust through transparency, consistent execution, and mutual accountability.
Behind every shipment is a patient who depends on timely access to safe, effective medicine. This awareness shapes our urgency, care, and attention to product integrity.
We pursue sustainable growth by investing in systems, capabilities, and people—continuously raising standards rather than simply expanding scale.
A decade of disciplined growth
Bio International Pharma Ltd. was founded in 2015 with the objective of establishing a professionally managed pharmaceutical distribution operation in Yemen. From the outset, expansion has followed infrastructure readiness, regulatory compliance, and demonstrated market demand.
Company established; pharmaceutical import and distribution licenses obtained from SBDMA.
Secured initial international manufacturing partnerships; opened first branch locations and warehouse facilities.
Expanded branch network and launched structured cold chain logistics infrastructure for biologics.
Portfolio expansion into insulin, growth hormones, and heparin products; customer base exceeded 500 active accounts.
Sustained multi-year growth and expansion of cold chain transport capacity.
Network expanded to 8 branches covering 13 governorates nationwide.
These milestones were achieved within a complex operating environment, reflecting operational resilience, structured execution, and sustained commitment to supply continuity.
Institutional management, structured accountability
Bio International Pharma Ltd. is managed through a structured leadership framework combining pharmaceutical distribution expertise, regulatory discipline, and commercial oversight. The organization emphasizes system-based management rather than personality-driven leadership.
Operations are organized across five core divisions:
Each division operates under defined responsibilities, documented procedures, and performance monitoring mechanisms aligned with corporate objectives.
These governance mechanisms reinforce transparency, operational discipline, and long-term organizational stability.
